Endocrine Disruptors: Commission takes steps to protect health and the environment
by Sabine Jülicher, Director for Food and Feed Safety, Innovation, DG Health and Food Safety, European Commission
Endocrine disruptors are substances, both natural and chemical, that can alter the function of the hormonal system in people and animals, causing adverse health effects for both.
The EU has for years tackled endocrine disruptors through legislation in sectors such as human health (including consumers and workers), animal health, food and feed and the environment.
Furthermore, the EU has one of the strictest systems in the world for assessing pesticides and biocides, whereby hundreds of substances are undergoing or have gone through a stringent scientific assessment process.
This precau
[...]
|
|
|
|
|
|
European Commissioner for Health and Food Safety Vytenis Andriukaitis announced the State of Health in the EU initiative for 2016-17 at the Employment, Social Policy, Health and Consumer Affairs Council (ESPCO) meeting in Luxembourg on 21 June 2016.
|
|
To assist policymakers prepare for possible local transmission of Zika in the EU, the European Centre for Disease Prevention and Control produced a policy briefing highlighting preparedness measures to minimise the risk of Zika virus spreading in continental Europe.
|
|
The Commission's annual report on Roma integration, adopted on 28 June 2016, provides the first overview of the measures put in place by Member States following the 2013 Council Recommendation on effective Roma integration measures.
|
|
After a one-year campaign on patient empowerment, EPF organised a roundtable with policy makers, stakeholders and patients how to take patient empowerment to the next level. The Commission's DG Health and Food Safety also participated.
|
|
Last month, the Commission’s independent Expert Panel that gives non-binding advice on matters related to “effective ways of investing in health” adopted three Opinions and one Memorandum related to access to healthcare and healthcare reforms.
|
|
FRESHER, or Foresight and Modelling for European Health Policy and Regulation, is an interdisciplinary research and foresight project funded by the EU programme Horizon 2020 that looks at future possibilities for tackling non-communicable chronic diseases.
|
|
Experts in case management, multimorbidity and training programmes for case managers from health institutes or public authorities, patients’ associations or academia are invited to take part. Responses will be used to map existing training programmes at the European level.
|
|
The European Food Safety Authority has set dietary reference values for vitamin B6 as part of its review of scientific advice on nutrient intakes.
|
|
Are you an NGO working in the field of Antimicrobial Resistance? Could your organisation use prize money of 10,000, 15,000 or 20,000 Euros? Submit your initiative for the EU Health Award 2016, now through 31 July 2016. Find out more and read about last year's Award here.
|
|
EU Press Releases
|
|
The European Medicines Agency (EMA) and the European Society for Medical Oncology (ESMO) recently held a workshop on the role of single-arm trials in the authorisation of new cancer medicines, which was broadcast live on 30 June 2016.
|
Forthcoming events
|
|
Millions of people across the world take part in World Hepatitis Day to raise awareness about viral hepatitis and to call for access to treatment, better prevention programs and government action.
|
Reporting from across Europe
|
|
A Nordic seminar on the policy on Roma brought together around 60 Nordic experts on Roma on 16 June 2016. The theme of the seminar held in Helsinki was the inclusion of the Roma population in decision-making that affects their lives
|
|
Ain Aaviksoo, Deputy Secretary General for E-services and Innovation at the Ministry of Social Affairs spoke to international experts about the personalized health system supported with digital solutions at the Cannes Lions Health conference, held 18 - 19 June 2016.
|
|
The Faecal Immonochemical Test (FIT) tests for hidden blood in stool samples, which can be an early sign of bowel cancer. Following a successful pilot involving 40,000 people, the UK National Screening Committee recommended the test should be rolled out nationally.
|
|
In the next issue
|
Vaccination
|
 |
|
Please do not reply to this message, as it is coming from an unmonitored email address.
If you wish to cancel your subscription to this newsletter click here
|
|
